Sphere Bio is a leading provider of integrated life sciences tools and solutions. Built upon proprietary picodroplet technology, the Company’s range of instruments and consumables for single cell analysis and isolation facilitate leading-edge research and accelerate biotherapeutic discovery and development workflows, including across emerging research areas, such as precision genome editing and cell therapy, streamlining the journey of discovery in labs, globally.
Zyme has been working with Sphere Bio since 2018 (formerly, Sphere Fluidics), providing strategic PR and communications support to raise awareness and elevate the Company’s brand to generate interest from commercial leads, investors, and partners. During this time, Zyme has harnessed its international network of life science trade media contacts and strong technical understanding, with an initial focus on establishing the Cyto-Mine® platform, and more recently supporting the launch of the Cyto-Mine® Chroma platform, and applications through science-driven communications that validate the technology and highlight its unique competitive advantages.
The strategy for the communications programme has evolved in line with Sphere Bio’s ongoing success and expansion, leveraging the team’s track-record and credibility to deliver value and results from objective-lead communications.
- Building a strong news pipeline to demonstrate maturation and commercial success, including global expansion, branding, new leadership and fundraising. Distributed 40+ press releases, achieving coverage in over 60 of the top target life science publications and local media, including STAT, Biocentury, GenomeWeb, Nature and Science.
- Leveraged Sphere Bio’s history and credentials to elevate profile with target audiences and position the team as industry KOLs, including securing a pipeline of editorial feature and article opportunities, including with GEN, GenomeWeb, Drug Discovery World, Labiotech, The Medicine Maker, and ITV News.
- Strategic communications planning to maximise exposure, such as securing press attendance at company-hosted events and directing customer-focused content project with FUJIFILM Diosynth Biotechnologies – including copywriting for article, blog, and application note detailing application of Cyto-Mine platform.
- Copywriting support to harness application materials and demonstrate value of technology, including drafting of technical and thought-leadership articles, application notes, and creation of blog ‘Spotlight Series’ to profile multi-disciplinary team.
- Supporting the development of a proactive and targeted marketing plan, focusing on third-party lead-gen with target publications to align with application focuses and the broader PR plan, to support consistent coverage and facilitate multiple touch points across all target audiences.
- Managing award entries for key industry awards, including successful nominations to leading programs such as Scrip, OBN, The Scientist Top 10 Innovations, and Frost & Sullivan Technology Innovation Leadership Award.
- Supporting recruitment efforts through PR opportunities with local Cambridge press, such as arranging company profile features, facilities tours, and successful nominations for employer- and technology-focused award programmes.
Maximising media briefing opportunities at conferences and advising on promotional activities to support return on investment, including securing media interviews at trade shows and highlighting lead-generation opportunities to support product launches.
Partnering with Zyme Communications has meant that our story is being told in all the right places. Their extensive network, deep life sciences expertise, and effortless collaboration have elevated our PR and communications strategy leading to enhanced media coverage, stronger stakeholder engagement, compelling messaging, and greater brand awareness. For example, our transformative rebrand from Sphere Fluidics to Sphere Bio was spotlighted as a major milestone, and our global expansion was featured in leading industry outlets. This has directly led to our increased recognition within the biotech ecosystem, reinforcing our expertise and credibility. Importantly, the team at Zyme are fantastic to work with - their genuine warmth and collaborative approach makes every project feel like a shared win!
Dr Claire Cox, Global Marketing Director, Sphere Bio